CD274 and glioblastoma: Despite the promise of immune checkpoint inhibitors upregulating in solid tumors, PD‐1/PD‐L1‐targeting checkpoint inhibitors and adoptive T‐cell transfer were often rendered ineffective against immunologically “cold” tumors like GBM.